|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2001-12-25
|
|
pubmed:abstractText |
The outcome of patients with advanced ovarian cancer is poor despite aggressive therapy including surgery and multiagent chemotherapy. Valid prognostic factors are necessary to estimate the course of the disease and to define biologically similar subgroups for analysis of therapeutic efficacy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0090-8258
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
84
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
21-31
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11748971-Adult,
pubmed-meshheading:11748971-Aged,
pubmed-meshheading:11748971-Aged, 80 and over,
pubmed-meshheading:11748971-DNA, Neoplasm,
pubmed-meshheading:11748971-Disease-Free Survival,
pubmed-meshheading:11748971-Female,
pubmed-meshheading:11748971-Flow Cytometry,
pubmed-meshheading:11748971-Humans,
pubmed-meshheading:11748971-Keratins,
pubmed-meshheading:11748971-Middle Aged,
pubmed-meshheading:11748971-Multivariate Analysis,
pubmed-meshheading:11748971-Neoplasm Staging,
pubmed-meshheading:11748971-Ovarian Neoplasms,
pubmed-meshheading:11748971-Ploidies,
pubmed-meshheading:11748971-Prospective Studies,
pubmed-meshheading:11748971-S Phase
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Ludwig-Maximilians-University, Munich, D-81377, Germany. rainer.kimmig@gyn.med.uni-muenchen.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
